SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001341004-18-000392
Filing Date
2018-07-10
Accepted
2018-07-10 16:18:39
Documents
3
Period of Report
2018-07-10
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8-k.htm 8-K 25379
2 EXHIBIT 99.1 - PRESS RELEASE ex99-1.htm EX-99.1 10170
3 biocryst.jpg GRAPHIC 3623
  Complete submission text file 0001341004-18-000392.txt   41885
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 18947141
SIC: 2836 Biological Products, (No Diagnostic Substances)